Came across an interesting clinical arrhythmia score for assessing severity of intra-atrial reentrant tachycardia (IART) [1]. Four parameters were considered for scoring: Documented IART, Frequency of cardioversion in
Clonal hematopoiesis of indeterminate potential (CHIP) is due to somatic mutations which cause expansion of hematopoietic stem cells. This is in the absence of overt hematologic malignancy. CHIP
HeartMate 3 is a fully magnetically levitated centrifugal flow intrathoracic left ventricular assist device. It has wider blood flow pathways compared to its predecessor Heartmate II. It has
Colchicine is a well known drug used in the treatment of acute gouty arthritis, having use in familial Mediterranean fever and acute pericarditis. Two recent studies – COLCOT
Canakinumab is a humanized monoclonal antibody targeting interleukin-1β. Experimental and clinical information had suggested that reducing inflammation even without affecting lipid levels may reduce the risk of cardiovascular
Angiopoietin-like protein 3 (ANGPTL3) is a protein synthesised by liver cells. It inhibits the expression lipoprotein lipase (LPL) gene. That will increase circulating triglycerides. Genetic activation of LPL
Inclisiran is a small interfering RNA (siRNA), which inhibit the production of PCSK9 in the liver. Unlike PCSK9 inhibitors which require monthly or biweekly injections, Inclisiran need be
I was really intrigued when I read in Braunwald’s textbook of Heart Disease that it was William Kouwenhoven, an engineer in Baltimore who described closed chest cardiac massage!
Popular classification of antiarrhythmic agents into Class I to IV was proposed by: A. Willis Hurst B. Eugene Braunwald C. Vaughan-Williams D. André Frédéric Cournand Correct answer: C.
